Erin LeBlanc to Medroxyprogesterone Acetate
This is a "connection" page, showing publications Erin LeBlanc has written about Medroxyprogesterone Acetate.
Connection Strength
0.148
-
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med. 2013 Aug 12; 173(15):1429-36.
Score: 0.112
-
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial. Obstet Gynecol. 2017 01; 129(1):121-129.
Score: 0.036